Goodwin Procter advised Cennox on the deal. Cennox announced its acquisition of FireKing Safety and Security. The deal enables Cennox to enter the traditional and smart safe...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Pathwire on the deal, while K&L Gates and Gernandt & Danielsson advised Sinch AB. Pathwire, along with its private equity owner Thoma Bravo...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Garuda Therapeutics on the deal. Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised G Squared Ascend I on the deal. Latham & Watkins represented Transfix. G Squared Ascend I (NYSE: GSQD), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Forge Global on the deal. Forge Global announced its definitive merger agreement with Motive Capital Corp (NYSE: MOTV.U) sponsored by affiliates of Motive Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Baker McKenzie advised Trillium Therapeutics on the deal, while Ropes & Gray LLP and Norton Rose Fulbright Canada represented Pfizer. Trillium Therapeutics (NASDAQ/TSX:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Omega Funds on the deal. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Kinstellar advised thredUP on the deal. Gugushev & Partners advised the Remix Global majority shareholders on the deal. ThredUp Inc. (NASDAQ: TDUP), one...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised RBC Bearings Incorporated on the deal, while Kirkland & Ellis advised ABB. RBC Bearings Incorporated (Nasdaq: ROLL) announced its definitive agreement to acquire the...
You must be a Standard 1 Year member to access this content.
